BACKGROUND: Cervical insufficiency is characterized by premature, progressive dilation and shortening of the cervix during pregnancy. If left unattended, this can lead to the prolapse and rupture of the amniotic membrane, which usually results in midtrimester pregnancy loss or preterm birth. Previous studies have shown that proinflammatory cytokines such as interleukin-1b, interleukin-6, interleukin-8, and tumor necrosis factor alpha are up-regulated in normal parturition but are also associated with preterm birth. Studies evaluating such markers in patients with cervical insufficiency have evaluated only their diagnostic potential. Even fewer studies have studied them within the context of cerclage surgery.
C ervical insufficiency is a condition characterized by premature, progressive dilation and shortening of the cervix during pregnancy. If left unattended, this gradual dilation can lead to the prolapse and eventual rupture of the amniotic membrane, which usually results in midtrimester pregnancy loss or preterm birth. 1 Cervical insufficiency is believed to be present in up to 1% of the obstetric population, but in women with a history of recurrent midtrimester losses, it is estimated to occur in 8% of cases. 1 However, the real prevalence of the condition is underestimated and difficult to determine. The condition develops and progresses in the absence of pain or other noticeable symptoms, and there is no objective diagnostic definition for cervical insufficiency.
Diagnosis is exclusion based and largely dependent on the experience of the clinician, who must rely on the patient's obstetric history and ultrasound screening to retrospectively diagnose the patient. 1, 2 This approach is particularly problematic for diagnosing primiparous women who lack such medical history.
Ultrasonographic assessment of cervical length has been traditionally used to assess the risk of preterm delivery, and in fact, women diagnosed with a secondtrimester cervical length of 15 mm have an almost 50% chance of having a spontaneous preterm delivery. 3 However, given that not all cases of short cervix result in a preterm delivery, 2, 3 additional factors must be involved in the development of cervical insufficiency. Furthermore, it is unclear whether a short cervix is an isolated factor or should be considered part of the spectrum of insufficiency as a disorder.
The current most accepted method of treatment is cervical cerclage, during which a surgical stitch is applied to mechanically prevent the cervix from further dilation. 4 The procedure, however, is not fully established to be the most effective preventive method for preterm delivery in these patients. Because of potential risks 5, 6 and contested efficacy compared with other treatments, [6] [7] [8] cerclage is generally recommended to high-risk patients such as women with a cervical anomaly or women with a history of 3 or more second-trimester losses. 1, 9, 10 Women without such a history seem to remain at Original Research ajog.org a high risk of preterm delivery with or without the procedure. 11 Understanding the processes that lead to cervical insufficiency would allow not only for a more effective treatment to be developed but also for better preventive and diagnostic strategies to be devised to prevent pregnancy losses and preterm deliveries in women affected by cervical insufficiency.
The morphological and biochemical changes involved in the maintenance of cervical competence are not well understood. In a normal pregnancy, cervical ripening is a regulated process that precedes labor contractions and is essential for the proper effacement and dilation of the cervix needed to transition into natural labor.
Previous studies have shown that during normal parturition, proinflammatory cytokines such as interleukin (IL)-1b, IL-6, IL-8, and tumor necrosis factor alpha (TNF-a) are up-regulated, even in the absence of infection, suggesting that normal labor is a proinflammatory processs. 12, 13 However, the same cytokines have also been associated with an increased risk of preterm delivery.
Studies evaluating inflammatory markers within the subset of patients with cervical insufficiency have generally focused on their predictive potential for cervical shortening, 14 risk of preterm birth, [15] [16] [17] or as evidence of subclinical infection. 18 Even fewer studies have evaluated these markers within the context of cerclage surgery, with most studies attempting to predict the effectiveness of the surgery and the risk of adverse outcomes. 5, [19] [20] [21] To our knowledge, no study has examined and compared the impact of local vs systemic inflammatory cytokines on the pathogenesis of cervical insufficiency or the effect of cerclage surgery on the local immune microenvironment of women with cervical insufficiency.
In this study, we aimed to examine the pathogenesis of cervical insufficiency by comparing the cytokine profile of pregnant women diagnosed with cervical insufficiency and referred for cerclage surgery with the cytokine profile of normal, gestational ageematched pregnant women. We also examined the effect of cerclage surgery on the local and systemic cytokine profile of women with cervical insufficiency.
Materials and Methods

Patient recruitment
Patients were recruited at the Outpatient Clinic of the Obstetrics Department at the Federal University of São Paulo, Brazil. The research protocol was approved by the ethics committee of the hospital, and written informed consent was obtained from all participants.
This was a prospective cohort study conducted over a period of 14 months, during which all patients meeting the inclusion/exclusion criteria were consecutively recruited into the study. The first group, the cervical insufficiency group, included women between 12 and 20 weeks of pregnancy diagnosed with cervical insufficiency and referred for cervical cerclage (n ¼ 28). Patients were recruited if they met all the following inclusion criteria:
1. An obstetric history of cervical insufficiency, defined as at least 1 pregnancy loss, late abortion or preterm labor characterized by early cervical dilatation without uterine contraction or pain, followed by premature rupture of membranes, fast labor, painless and with limited blood loss resulting in live concept without congenital malformation. 2. Patients with a history of previous preterm birth or hysterosalpingography or positive Hegar test (!8 mm at the level of the internal orifice of the cervix) confirming the association with cervical insufficiency. Exclusion criteria included multiple gestation, fetal death, autoimmune diseases, preexisting systemic disease, Mullerian uterine anomalies and uterine malformation, in vitro fertilization treatment, placental abruption, and/or evidence of vaginal infection.
The second group, the control group (n ¼ 19), included patients at the same gestational age (12e20 weeks), without any maternal or fetal disorder, who also met the exclusion criteria. Patient characteristics are summarized in the Table. Patients were identified during their monthly routine examination. Once a potential study subject was identified, a questionnaire was used to determine whether the patient satisfied the study criteria. The questionnaire was administered by a previously trained laboratory student in the form of an interview during the patient visit and filled out by the student. If the patient met all criteria, the patient was asked to sign a consent form. Finally, samples were collected by the resident or doctor conducting the examination, with the supervision of the student. For normal pregnant women, samples were collected during their routine visit. For women with cervical insufficiency, samples were collected once they had been admitted to the hospital in preparation for surgery, either on the day before or immediately before the cerclage surgery.
Cerclage was done using the McDonald technique with 2 circular sutures with string Prolene 2, under epidural anesthesia. Patients who underwent cerclage were not administered progesterone, steroids, or Indocin before or after the surgery.
Sample collection and processing
To measure local and systemic concentrations of cytokines, we collected peripheral blood and cervicovaginal fluid (CVF) from each patient. All samples were processed within 2 hours after collection. Blood was collected in a serum vacutainer (5 mL of blood, 13 Â 100 mm Â 5.0 mL BD Vacutainer SST II Plus plastic serum tube, Gold BD Hemogard closure, Becton Dickinson, São Paulo, Brazil).
Once in the laboratory, blood was centrifuged (3500 rpm, 10 minutes, 
22
C) to separate the serum, which was then aliquoted into sterile 0.6 mL microfuge tubes and stored at e80 C. The CVF was collected using a sterile, individually packed plastic Pasteur pipette (0.5e1 mL of CVF) from the posterior vaginal fornix, as close as possible to the cervical canal.
Two samples were collected from each patient to ensure we obtained enough sample, particularly in cases who had a very small amount of secretion. As soon as the CVF was collected, the portion of the pipette containing the fluid was cut with scissors, placed in a 2 mL microfuge tube, sealed, and placed on ice for transport. Once in the laboratory, the CVF was washed out of the tip with 500 mL of sterile, cold phosphate-buffered saline and immediately stored at e80 C. To determine the effect of cerclage surgery on cytokine concentrations in patients with cervical insufficiency, 2 sets of samples were collected. The first set was collected before surgery, whereas the second set was collected approximately a month later, during their routine followup visit.
Protein extraction and cytokine profiling
Protein concentration in CVF samples was normalized before performing cytokine profiling. Total protein concentrations were determined using a Pierce BCA assay protein kit (catalog 23225; ThermoFisher Scientific, Toronto, Ontario, Canada) following the manufacturer's instructions. All samples were normalized to a concentration of 50.716 mg/mL (diluted with sterile phosphate-buffered saline) to match the sample with the lowest total protein concentration.
To measure cytokine concentration, both serum and CVF samples were analyzed using a commercially available multiplex assay (Eve Technologies Inc, Calgary, AB, Canada) that included 13 selected inflammatory cytokines and chemokines: granulocyte-macrophage colony-stimulating factor, interferon gamma (IFNg), monocyte chemoattractant protein-1 (MCP-1), tumor necrosis factor alpha (TNFa), and IL-1b, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12 (p70), and IL-13.
Briefly, uniquely color-coded polystyrene beads were coupled with capture antibodies for each respective target cytokine. The antibody-coupled beads were combined and incubated with each sample in a 96 well plate. A Bio-plex 200 system (Eve Technologies Inc, Calgary, Alberta, Canada) was used to measure the fluorescent intensity signal, which is in direct proportion to the protein bound to the specific analyte bead population. The observed concentration for each target cytokine was calculated against a standard curve regression, and all values were recorded in units of picograms per milliliter. Values that fell below the minimum detection range (0.65 pg/mL) were set at zero (sensitivity, 0.65e10 pg/mL).
Statistical analysis
Statistical analyses were performed with Sigma Stat 3.5 (Systat Software Inc., San Jose, CA) and GraphPad Prism 7 (GraphPad Software Inc., La Jolla, CA). All values are expressed in picograms per milliliter. Differences between controls and patients with cervical insufficiency were determined using a 1-way, repeated-measures analysis of variance (ANOVA) with Dunn's post hoc test or a 
Results
Patient characteristics and outcomes
The characteristics of our study groups are summarized in the Table. There were no significant differences in average age or body mass index between control women and women with cervical insufficiency.
We also examined gravidity, defined as the number of previous pregnancies including any lost pregnancies, and parity, defined as the number of births at a gestational age of 24 weeks or more. We found that gravidity in women with insufficiency was twice as high as in control women, while there were no significant differences in parity (Table) , meaning that women with insufficiency have gone through more pregnancies but had a similar average number of previous deliveries as control women.
Additionally, we found that women with insufficiency experienced a higher number of miscarriages, stillbirths (defined as fetal death at or after the 20th week of pregnancy), and neonatal deaths (defined as the death of a live-born baby in the first 28 days of life) than control women, which supports the previous observation these patients have experienced more pregnancies than control women but that these pregnancies were often not successful. These results highlight the fact that women with cervical insufficiency have a higher risk of losing their pregnancy compared with normal women.
Interestingly only 3 of the 28 women with cervical insufficiency had previously been prescribed cerclage. There were no significant differences in the number of preterm deliveries between the 2 groups. We were able to follow up with 21 of the 28 women with cervical insufficiency to determine pregnancy outcomes. Of 21 patients, 19 delivered successfully and 2 lost the pregnancy. Of the successful deliveries, 12 had a cesarean delivery and 7 had a vaginal delivery.
Women with cervical insufficiency express higher local levels of proinflammatory cytokines than control women
We hypothesized that women with cervical insufficiency would have heightened inflammatory cytokines potentially contributing to inflammation compared to normal pregnant women. We also wanted to determine whether cervical cerclage would have any impact on the local cytokine levels. To establish this, we compared cytokine levels in CVF samples between control women at the time of admission and women with cervical insufficiency both before and after cerclage. We found that levels of IL-1b (control, precerclage, postcerclage median, 0.28, 1.88, 0.49; P ¼ .004), IL-6 (control, precerclage, postcerclage median, 0, 0.64, 0; P .001), IL-12 (control, precerclage, postcerclage median, 0.42, 0.64, 0.31; P ¼ .014), MCP-1 (control, precerclage, postcerclage median, 2.06, 7.81, 1.61; P .001), and TNFa (control, precerclage, postcerclage median, 0, 0.1, 0; P ¼.002) were significantly higher in the CVF of patients with cervical insufficiency compared with controls but only before cerclage surgery (Figure 1) .
When comparing patients after cerclage vs control women at the time of admission to the study, we found no differences. These results show not only that patients with cervical insufficiency have higher-than-normal levels of proinflammatory cytokines but also suggest that local levels of these cytokines became closer to normal after the surgery.
Women with cervical insufficiency and control women show no differences in systemic levels of proinflammatory cytokines
To determine whether patients with cervical insufficiency exhibit systemic inflammation, we screened serum Original Research OBSTETRICS ajog.org samples and compared between controls and patients cervical insufficiency. We also wanted to determine whether cervical cerclage would have an effect on the systemic cytokine levels when compared with controls. We found no significant differences in circulating cytokine levels between control women and women with cervical insufficiency before or after cervical cerclage (Figure 2 ). These findings suggest that inflammation is not systemic but is rather confined to the local environment of the cervix.
Cervical cerclage intervention led to a decrease in local and circulating levels of proinflammatory cytokines
To further evaluate the effect of cervical cerclage on the cytokine profile of patients with cervical insufficiency, we selected patient-matched samples of serum and CVF and performed a paired comparison of cytokine levels before and after cerclage surgery. In CVF samples, we detected a significant decrease in the levels of IL-1b (precerclage, postcerclage median, 0.83, 0.49; P ¼ .002), IL-6 (precerclage, postcerclage median, 0.61, 0; P .001), IL-8 (precerclage, postcerclage median, 227.9, 42.41; P ¼ .002), MCP-1 (precerclage, postcerclage median, 8.35, 0.47; P .001), and IFNg (precerclage, postcerclage median, 0.56, 0.14; P ¼ .039) after surgery ( Figure 3 ). Of these cytokines, IL-8 and IFNg were significant only when comparing precerclage vs postcerclage values in patients with cervical insufficiency. However, IL1b, IL-6, and MCP-1 match our previous findings in which they are also higher in patients with cervical insufficiency when compared with control. No differences were found for other cytokines.
When we performed the same analysis in the serum of patient-matched cervical insufficiency samples, only MCP-1 showed a significant decrease after cerclage surgery, which matches our findings in CVF. MCP-1 was the only cytokine that showed statistically significant differences across all comparisons.
Comment
Principal findings
To our knowledge, this is the first study to report that women with cervical insufficiency have higher levels of proinflammatory cytokines in CVF compared with gestation-matched normal pregnant women. Furthermore, we report that local and systemic concentrations of cytokines are significantly and differentially affected by cervical cerclage intervention.
When comparing women with cervical insufficiency with control women, cytokines measured in the CVF were significantly higher in the patients before undergoing surgery, but such differences disappeared after surgery as the levels of IL-1b, IL-6, IL-12 (p70), and MCP-1, and TNFa became equivalent to that of control women at the time of admission. Meanwhile, the serum concentrations of the evaluated cytokines showed no differences between patients with cervical insufficiency neither before nor after surgery. When looking at patients with 
Cervical insufficiency vs control in serum
Serum cytokine levels were not significantly different between control sand patients with cervical insufficiency, both before and after surgery. Only the cytokines that were significant in other tests were selected to be shown for comparison. One-way analysis of variance or Kruskal-Wallis test was used ajog.org OBSTETRICS Original Research cervical insufficiency only, levels of IL1b, IL-6, IL-8, MCP-1, and IFNg decreased significantly after surgery, further supporting the notion that cerclage is a favorable procedure for the high-risk patient with cervical insufficiency that is typically referred for surgery.
These findings suggest that cerclage helps reduce inflammation in these patients and, perhaps more importantly, that the molecular pathways involved in the progression of cervical insufficiency may be primarily driven by local changes rather than systemic.
Results in context
Our findings support previous studies showing the local role of inflammatory cytokines in the process of cervical ripening and parturition. 12 Our analyses showed that IL-8 decreased significantly in the CVF of insufficiency patients after intervention with cerclage, while it was not significantly different between women with cervical insufficiency and control women.
IL-8 has been consistently associated with the process of cervical dilation 23 and cervical ripening for labor. [24] [25] [26] Furthermore, IL-8 has been shown to be induced by mechanical stretch of human uterine smooth muscle in vitro. 27 If smooth muscle stretch is enough to modulate the expression of IL-8, it may explain why mechanically supporting the cervix via cerclage induced a decrease of local levels of IL-8 in these patients.
Interestingly, IL-1b has been previously shown to be capable of inducing IL-8 expression in tissue samples of lower uterine segment fibroblasts in vitro 28 and can even act synergistically with other cytokines in this process. 29 Furthermore, IL-1b has been strongly associated with preterm birth risk as well. 12, 30 Our results show that IL-1b not only decreased significantly after cerclage surgery but was also significantly higher in the CVF of patients with cervical insufficiency compared with controls. After the surgery, these higher levels became similar enough to the control group to show no statistically significant differences, suggesting that the cervical cerclage may have helped reduce the inflammation associated with the dilation and shortening of the cervix.
IL-6 has been strongly associated with intrauterine infection and preterm birth when high levels are detected in the amniotic fluid 31, 32 as well as in cervical fluid.
33, 34 Our results show that IL-6 was significantly higher in women with cervical insufficiency and that it decreased significantly after surgery but only in the CVF. This local modulation of IL-6 may indicate its importance in the process of parturition.
The key role of IL-6 for the timing of parturition has been shown in mice 35 and humans, 36 in which it has also been correlated with myometrial contractility, secreted during labor in synchrony with contractions. 37 This may explain the fact that the changes in IL-6 were detectable in CVF only and not in serum.
MCP-1 was the only cytokine found to significantly decrease after surgery in both serum and CVF in patients with cervical insufficiency, and it was also lower in control patients compared with patients with cervical insufficiency before the cerclage. MCP-1 has been associated with preterm birth and cervical ripening, with levels increasing during parturition. 26 In a study of women with a short cervix, MCP-1 in the amniotic fluid was found to be the most predictive of spontaneous preterm birth of 25 other cytokines analyzed. 38 Interestingly, MCP-1 expression has been shown to be induced by mechanical stretch in vitro, 39 which may explain why preventing stretch via cerclage induced a reduction in MCP-1.
Clinical implications
Our findings support the idea that women with cervical insufficiency have a higher proinflammatory profile that likely puts them at a higher risk of preterm delivery. Given that most of our findings point to a local modulation of the inflammatory profile in these patients, the fact that IL-8, IL-6, and MCP-1 are responsive to mechanical Original Research OBSTETRICS ajog.org stress may explain the effect of the cerclage placement in reducing the levels of these cytokines. Also, given their key role in the timing and regulation of labor, their increased expression would explain why these women are experiencing a gradual but premature progress into labor. However, we cannot explain why these women are experiencing the premature up-regulation of these cytokines in the first place.
One explanation is the presence of subclinical infection, which has been shown to have a higher rate of occurrence in patients with cervical insufficiency. 18 We could also speculate that in cases of asymptomatic insufficiency not otherwise explained by any other abnormality, these women could have a defect or particular trait that makes them more susceptible than normal to the stretching of the uterus caused by the pregnancy. A previous study by Warren et al 40 found 2 genetic polymorphisms associated with cervical insufficiency, which supports this possibility.
Research implications
A previous study had similar findings to this study, of up-regulated inflammatory cytokines in the amniotic fluid of women referred to emergency cerclage compared with controls. 19 However, we were able to detect these changes in CVF, which is less invasive than sampling amniotic. The congruence between our findings in CVF and findings in previous studies measuring cytokines in the amniotic fluid may indicate that sampling and analysis of CVF could be sufficient to achieve the same results with a less invasive procedure, although more studies are needed to evaluate this possibility. Such an approach would be a valuable diagnostic alternative to identify women at risk of developing cervical insufficiency.
Strengths and limitations
Some of the limitations of this study include a smaller sample size compared with some other studies. However, given the rarity of the condition, we believe that this cohort still provides valuable evidence on the events involved in the development and progression of cervical insufficiency.
Our study also focused on the gestational window during which cervical insufficiency is usually diagnosed, which limits our ability to pinpoint the onset of the inflammatory process. We have provided evidence that in patients with a history of cervical insufficiency, intervention cerclage is a beneficial option. Although the potential benefit of a prophylactic placement cannot be confirmed with our findings, we can speculate that prophylactic placement may help prevent the mechanical stressinduced production of inflammatory cytokines.
The use of a targeted multiplex cytokine assay means that we may be unaware of the role of other mediators in the inflammatory process of cervical insufficiency, which we cannot rule out. However, our findings offer some insight into the physiological effects of cervical cerclage on the immune microenvironment of patients with cervical insufficiency, which will hopefully aid the direction of future studies. Further studies need to be conducted to further explore the mechanisms and triggers that lead to an increase in proinflammatory cytokines in cervical insufficiency.
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